# Stemcentrx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/stemcentrx

- Industry: Biotechnology
- Headquarters: San Francisco, US
- Website: http://www.stemcentrx.com
- Total disclosed funding: $474M
- Latest round: Series G (Aug 31, 2015)
- Investors on record: 6

## About

Founded in 2008 and based in San Francisco, California, Stemcentrx develops therapies and diagnostics for cancer patients.

## Funding rounds

- Series G, Aug 31, 2015, $250M — Hong Shan, Founders Fund, Fidelity Investments, ARTIS Ventures, Silicon Valley Bank
- Series F, May 16, 2014, $200M — Hong Shan, Founders Fund, ARTIS Ventures, Capital Group
- Series C, Mar 11, 2011, $24M — ARTIS Ventures

## Investors

- ARTIS Ventures (https://capitalatlas.ai/funds/artis-ventures) — Series C, Series F, Series G
- Hong Shan — Series F, Series G
- Founders Fund (https://capitalatlas.ai/funds/founders-fund) — Series F, Series G
- Capital Group — Series F
- Fidelity Investments (https://capitalatlas.ai/funds/fidelity-investments) — Series G
- Silicon Valley Bank — Series G